Keep lying to yourself mate, but when you lie to the community here, it will be called out. Nowhere in the MSB or Novartis published deal conditions does it say success of COVID ARDS is a condition of the upfront payment. If you think that the CHF resutls and synergy with Entresto doesnt justify a paltry $55m payment just to be in the tent then you are either:
1. a big lying bottom feeding shorter and paid downramper, in which case everyone should put you on ignore
2. Stupider than we thought, in which case everyone should put you on ignore
Ann: Appendix 4C Quarterly Activity Report, page-80
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
0.025(1.79%) |
Mkt cap ! $1.621B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.43 | $1.40 | $1.324M | 939.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 11952 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 80936 | 4 |
View Market Depth
| Last trade - 10.50am 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |